Skip to main content

Edgemond James's Form 4 filing

United Therapeutics Corp (UTHR) · filed Aug 20, 2024

Accession no.
0001415889-24-021694
Filed
Aug 20, 2024
Trade date
Aug 19, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.58M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edgemond JamesCIK 0001636178Officer (CFO AND TREASURER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2024Common StockMOption exerciseAcquired+3,266$120.26+$392,769.164,844Direct
Aug 19, 2024Common StockSSaleDisposed−3,266$329.02−$1,074,579.321,578Direct
Aug 19, 2024Common StockMOption exerciseAcquired+3,400$117.76+$400,3844,978Direct
Aug 19, 2024Common StockSSaleDisposed−3,400$329.02−$1,118,6681,578Direct
Aug 19, 2024Common StockMOption exerciseAcquired+816$120.26+$98,132.162,394Direct
Aug 19, 2024Common StockSSaleDisposed−571$329.02−$187,870.421,823Direct
Aug 19, 2024Common StockMOption exerciseAcquired+850$117.76+$100,0962,673Direct
Aug 19, 2024Common StockSSaleDisposed−591$329.02−$194,450.822,082Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 19, 2024Common StockMOption exerciseDisposed−3,266$0.00$045,734Direct
Aug 19, 2024Common StockMOption exerciseDisposed−3,400$0.00$0159,100Direct
Aug 19, 2024Common StockMOption exerciseDisposed−816$0.00$044,918Direct
Aug 19, 2024Common StockMOption exerciseDisposed−850$0.00$0158,250Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)